Exelixis reported $2.11B in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Akebia Therapeutics AKBA:US $ 137.15M 37.48M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Bayer BAYN:GR € 31103M 714M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Bristol Myers Squibb BMY:US $ 37213M 405M
Cytokinetics CYTK:US $ 249.02M 232.53M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Eisai 4523:JP Y 730336M 7784M
Eli Lilly And LLY:US $ 7757M 1312.6M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Exelixis EXEL:US $ 2112.45M 69.37M
Genmab GEN:DC DK 21285M 1033M
Glaxosmithkline GSK:US $ 15426M 49M
Immunogen IMGN:US $ 77.09M 8.63M
IONIS PHARMACEUT IONS:US $ 531M 51.67M
Macrogenics MGNX:US $ 291.44M 27.61M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Moderna Inc MRNA:US 10.12B 3.42B
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Neurocrine Biosciences NBIX:US $ 1346M 66.8M
Novartis NOVN:VX SF 56771M 2729M
Puma Biotechnology PBYI:US $ -10.92M 40.39M
Seattle Genetics SGEN:US $ 3164.96M 226.32M
Takeda 4502:JP Y 5323935M 24161M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Xencor XNCR:US $ 618.86M 28.08M
YTE INCY:US $ 3148.66M 212.8M